C vs PRCT · P/E 16, rev $85.22B vs rev $224.5M
Citigroup Inc. (C) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
C currently screens at market cap $214.73B and trailing P/E 15.5. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the C and PRCT stock pages for the full models.
Not investment advice.